Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Regulatory News (ARIX)

  • There is currently no data for ARIX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

10 Sep 2018 16:24

Arix Bioscience Plc - Holding(s) in Company

Arix Bioscience Plc - Holding(s) in Company

PR Newswire

London, September 10

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:Arix Bioscience plc
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rightsX
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
NameChristopher Chipperton
City and country of registered office (if applicable)
4. Full name of shareholder(s) (if different from 3.)v
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reachedvi:21 August 2018
6. Date on which issuer notified (DD/MM/YYYY):22/08/18
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached5.3%0.00%5.3%134,823,243
Position of previous notification (if applicable)7.74%0.00%7.74%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)Number of voting rightsix% of voting rights
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)Direct (Art 9 of Directive 2004/109/EC) (DTR5.1)Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Ordinary GB00BD450747,147,91405.3%0.00%
SUBTOTAL 8. A7,147,9145.3%
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrumentExpiration datexExercise/ Conversion PeriodxiNumber of voting rights that may be acquired if the instrument is exercised/converted.% of voting rights
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrumentExpiration datexExercise/ Conversion Period xiPhysical or cash settlementxiiNumber of voting rights % of voting rights
SUBTOTAL 8.B.2

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)
Namexv% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional informationxvi

Place of completionDubai, United Arab Emirates
Date of completion10 September 2018
Date   Source Headline
28th May 20214:56 pmEQSTransaction in own shares
27th May 20214:58 pmEQSTransaction in own shares
26th May 20214:53 pmEQSTransaction in own shares
25th May 20215:24 pmEQSTransaction in own shares
24th May 20215:04 pmEQSTransaction in own shares
21st May 20215:09 pmEQSTransaction in own shares
20th May 20215:27 pmEQSTransaction in own shares
20th May 20217:00 amEQSChange of registered office
19th May 20215:06 pmEQSTransaction in own shares
18th May 20215:33 pmEQSTransaction in own shares
18th May 20217:00 amEQSNotice of 2021 Annual General Meeting
17th May 20215:40 pmEQSTransaction in own shares
14th May 20215:02 pmEQSTransaction in own shares
13th May 20215:16 pmEQSTransaction in own shares
12th May 20215:12 pmEQSTransaction in own shares
12th May 20214:35 pmEQSAutolus to present additional data in AUTO1 in IBCL 
11th May 20215:43 pmEQSTransaction in own shares
10th May 20215:21 pmEQSTransaction in own shares
7th May 20215:19 pmEQSTransaction in own shares
6th May 20215:23 pmEQSTransaction in own shares
5th May 20215:16 pmEQSTransaction in own shares
4th May 20215:15 pmEQSTransaction in own shares
4th May 20217:00 amEQSTotal Voting Rights
30th Apr 20214:59 pmEQSTransaction in own shares
30th Apr 20217:00 amEQSOutcome of Strategic Implementation Review and Directorate Change
29th Apr 20215:10 pmEQSTransaction in own shares
28th Apr 20215:14 pmEQSTransaction in own shares
28th Apr 202112:02 pmEQSAmplyx Pharmaceuticals acquired by Pfizer
27th Apr 20215:29 pmEQSTransaction in own shares
27th Apr 20212:00 pmEQSLogicBio announces clinical and corporate updates
26th Apr 20215:32 pmEQSTransaction in own shares
23rd Apr 20215:11 pmEQSTransaction in own shares
22nd Apr 20215:15 pmEQSTransaction in own shares
21st Apr 20215:27 pmEQSTransaction in own shares
20th Apr 20215:31 pmEQSTransaction in own shares
19th Apr 20215:09 pmEQSTransaction in own shares
16th Apr 20215:18 pmEQSTransaction in own shares
15th Apr 20215:09 pmEQSTransaction in own shares
14th Apr 20215:13 pmEQSTransaction in own shares
13th Apr 20215:13 pmEQSTransaction in own shares
12th Apr 20215:23 pmEQSTransaction in own shares
9th Apr 20215:44 pmEQSTransaction in own shares
8th Apr 20215:28 pmEQSTransaction in own shares
8th Apr 20218:19 amRNSProactive One2One Virtual Investor Forum
8th Apr 20217:00 amEQSArix to Present at the Proactive One2One Virtual Investor Forum
7th Apr 20215:47 pmEQSTransaction in own shares
7th Apr 20217:00 amEQSArtios announces collaboration with Novartis to create next generation DDR cancer therapies 
6th Apr 20215:26 pmEQSTransaction in own shares
1st Apr 20215:20 pmEQSTransaction in own shares
1st Apr 20217:00 amEQSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.